Details for 2019803950

Up to date per 10.05.2026

Actions

Title / Product Name

VERFAHREN ZUR BEHANDLUNG VON KREBS UND ZUR STEIGERUNG DER WIRKSAMKEIT VON T-ZELL-UMLEITENDEN THERAPEUTIKA

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2019803950

EP Publication Number

3793606

E-Number

1914765

Language

PCT Number

IB19054034

Publication Date

24.03.2021 A

29.04.2026 B1

Registration Date

29.04.2026

AT Publication Date

15.05.2026

Application Date

15.05.2019

Registration Number

Priorities

16.05.2018

201862672222 P

26.09.2018

201862736804 P

02.05.2019

201962842080 P

IPC

A61K 39/395 20060101AFI20220728BHEP

Maximum Duration of Protection

15.05.2039

Owner

Janssen Biotech, Inc.800/850 Ridgeview Drive Horsham, PA 19044US

Stichting Amsterdam UMCDe Boelelaan 1117 1081 HV AmsterdamNL

Representative

No representatives present

Inventor

ADAMS, Homer2005 Richland Terrace Quakertown, Pennsylvania 18951US

GAUDET, Francois1400 McKean Road Spring House, Pennsylvania 19477US

FRERICHS, KrisDe Boelelaan 1085 1081 HV AmsterdamNL

VAN DE DONK, NielsDe Boelelaan 1085 1081 HV AmsterdamNL

VERKLEIJ, Christie C.P.M.De Boelelaan 1085 1081 HV AmsterdamNL

Information about Fees